Advertisement

Indications and Contraindications for Bariatric Surgery

  • David A. Provost
Chapter

Abstract

Defining the indications for metabolic and bariatric surgery begins with an assessment of the risk-benefit of a given procedure. Significant advances in surgical techniques, reductions in operative risk, and greater knowledge of the potential risk of untreated obesity have greatly altered the risk-benefit of surgery since 1991. In addition, the health and mortality risk of untreated obesity is better defined and greater than was appreciated in 1991. The result is a shift in the risk-benefit favoring surgery, leading to consideration of lowering the body mass index (BMI) indications for metabolic and bariatric surgery. There are few absolute contraindications to metabolic and bariatric surgery. Most would be included in lists of contraindications of any elective surgical procedure. Patients deemed a prohibitive operative risk should not be offered surgery, including those with contraindications to general anesthesia or uncorrectable coagulopathy. Bariatric surgery should not be performed on patients with limited life expectancy due to irreversible cardiopulmonary or other end-organ failure or metastatic or inoperable malignancy. Patients who are pregnant or who expect to be pregnant within 12 months of surgery should be deferred. Active drug or alcohol abuse is a relative contraindication to surgery, as is untreated severe psychiatric illness. Metabolic and bariatric surgery should be postponed in patients with active peptic ulcer disease until successful treatment has been confirmed.

Keywords

Human Immunodeficiency Virus Obstructive Sleep Apnea Bariatric Surgery Human Immunodeficiency Virus Infection Limited Life Expectancy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Int Med. 1991;115:956–61.Google Scholar
  2. 2.
    Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis. 2013;9:159–91.PubMedCrossRefGoogle Scholar
  3. 3.
    Buchwald H. 2004 ASBS consensus conference: consensus conference statement – bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payors. Surg Obes Relat Dis. 2005;1:371–81.PubMedCrossRefGoogle Scholar
  4. 4.
    Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for type 2 diabetes. Surg Obes Relat Dis. 2011;7:433–47.PubMedCrossRefGoogle Scholar
  5. 5.
    Dorman RB, Abraham AA, Al-Refaie WB. Bariatric surgery outcomes in the elderly: an ACS NSQIP study. J Gastrointest Surg. 2012;16:35–44.PubMedCrossRefGoogle Scholar
  6. 6.
    Michalsky M, Reichard K, Inge T, Pratt J, Lenders C. Update: ASMBS pediatric committee best practice guidelines. Surg Obes Relat Dis. 2012;8:1–7.PubMedCrossRefGoogle Scholar
  7. 7.
    LeMont D, Moorehead MK, Parish MS, Reto CS, Ritz SJ. Suggestions for the pre-surgical psychological assessment of bariatric surgery candidates. ASMBS 2004; http://asmbs.org/2012/06/pre-surgical-psychological-assessment/.
  8. 8.
    Pull CB. Current psychological assessment practices in obesity surgery programs: what to assess and why. Curr Opin Psychiatry. 2010;23:30–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 1999;84:1513–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Shimizu H, Phuong V, Maia M, Kroh M, Chand B, Schauer PR, et al. Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis. 2013;9:1–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Flancbaum L. Initial experience with bariatric surgery in asymptomatic human immunodeficiency virus-infected patients. Surg Obes Relat Dis. 2005;1:73–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Selke S, Norris S, Osterholzer D, Fife KH, DeRose B, Gupta SK. Bariatric surgery outcomes in HIV-infected subjects: a case series. AIDS Patient Care STDS. 2010;24:545–50.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of SurgeryTexas Health Presbyterian HospitalDentonUSA

Personalised recommendations